Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China

Fig. 2

Drug susceptibility test coverage (A) and rifampicin-resistant tuberculosis detection (B) among pulmonary tuberculosis patients in Shanghai, China, in the first half of 2018. RR-TB = rifampicin-resistant tuberculosis. cDST = conventional drug susceptibility test. Xpert = Xpert MTB/RIF. Blue, green and red bars indicates the contribution of cDST alone, Xpert alone, and when both cDST & Xpert were done

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us